Search research articles
Contact Us
Filters
Showing results (71-80 of 207) with videos related to
Page
of 21
Sort By:
Breast Cancer Research and Treatment
|
December 13, 2019
Evaluation of the anti-Thomsen-Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer
Sabine Heublein, Markus Egger, Junyan Zhu, et al.
Anticancer Research
|
May 30, 2008
Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers
Bettina Toth, Rienk Nieuwland, Susanne Liebhardt, et al.
Medicina (Kaunas, Lithuania)
|
November 27, 2021
The Role of Chemokines in Cervical Cancers
Fabian Garrido, Carl Mathis Wild, Johanna Mittelberger, et al.
Endocrine Connections
|
April 28, 2018
Prostaglandin E<sub>2</sub> receptor 3 signaling is induced in placentas with unexplained recurrent pregnancy losses
Yao Ye, Aurelia Vattai, Nina Ditsch, et al.
Journal of Cancer Research and Clinical Oncology
|
June 14, 2020
Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
Nina Ditsch, Sabine Heublein, Udo Jeschke, et al.
Cancers
|
August 7, 2021
Cytoplasmic Localization of RXRα Determines Outcome in Breast Cancer
Alaleh Zati Zehni, Falk Batz, Vincent Cavaillès, et al.
Cancers
|
April 16, 2020
High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
Anna Trebo, Nina Ditsch, Christina Kuhn, et al.
International Journal of Molecular Sciences
|
March 1, 2019
The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status
Udo Jeschke, Xi Zhang, Christina Kuhn, et al.
Breast Cancer Research : BCR
|
April 14, 2021
Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs)
Lili Lin, Christina Kuhn, Nina Ditsch, et al.
International Journal of Molecular Sciences
|
June 26, 2020
EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases
Alaleh Zati Zehni, Udo Jeschke, Anna Hester, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 207) with videos related to
Sort By:
Page
of 21
Breast Cancer Research and Treatment
|
December 13, 2019
Evaluation of the anti-Thomsen-Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer
Sabine Heublein, Markus Egger, Junyan Zhu, et al.
Anticancer Research
|
May 30, 2008
Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers
Bettina Toth, Rienk Nieuwland, Susanne Liebhardt, et al.
Medicina (Kaunas, Lithuania)
|
November 27, 2021
The Role of Chemokines in Cervical Cancers
Fabian Garrido, Carl Mathis Wild, Johanna Mittelberger, et al.
Endocrine Connections
|
April 28, 2018
Prostaglandin E<sub>2</sub> receptor 3 signaling is induced in placentas with unexplained recurrent pregnancy losses
Yao Ye, Aurelia Vattai, Nina Ditsch, et al.
Journal of Cancer Research and Clinical Oncology
|
June 14, 2020
Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
Nina Ditsch, Sabine Heublein, Udo Jeschke, et al.
Cancers
|
August 7, 2021
Cytoplasmic Localization of RXRα Determines Outcome in Breast Cancer
Alaleh Zati Zehni, Falk Batz, Vincent Cavaillès, et al.
Cancers
|
April 16, 2020
High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
Anna Trebo, Nina Ditsch, Christina Kuhn, et al.
International Journal of Molecular Sciences
|
March 1, 2019
The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status
Udo Jeschke, Xi Zhang, Christina Kuhn, et al.
Breast Cancer Research : BCR
|
April 14, 2021
Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs)
Lili Lin, Christina Kuhn, Nina Ditsch, et al.
International Journal of Molecular Sciences
|
June 26, 2020
EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases
Alaleh Zati Zehni, Udo Jeschke, Anna Hester, et al.
Page
of 21